Projekt
A Phase 3, Multi-Site, Open-Label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Automatisch geschlossen · 2011 bis 2015
Anliker Mark
Art
Reichweite
Bereiche
Status
Start
Ende
Finanzierungsart
Studiendesign
Kurzbeschreibung/Zielsetzung
The main objective of this study is to evaluate the long-term safety of CP-690,550 in patients being treated for moderate to severe chronic plaque psoriasis. This is an open label extension study available to patients who participated in one of the qualifying studies with CP-690,550 providing entry criteria is met.